Post navigation

Screen all psoriasis patients for hepatitis before immunosuppressive therapy

Routine screening for hepatitis B
and C has become a must prior to initiation of chronic immunosuppressive
therapy for psoriasis.

“Universal screening for hepatitis B and hepatitis C
infection is not optional in 2013,” he stressed at the Hawaii
Dermatology Seminar sponsored by Global Academy for Medical
Education/Skin Disease Education Foundation.

That said, professional society guidelines are at
odds and in flux on this issue. The American Association for the Study
of Liver Diseases, the European Association for the Study of the Liver,
and the Centers for Disease Control and Prevention all recommend routine
screening for hepatitis B surface antigen and hepatitis B core antibody
prior to initiation of immunosuppressive therapy. The CDC also
recommends universal pretreatment testing for antibody to hepatitis B
surface antibody.

The study is aimed at assessing the safety and immunogenicity of HCV prime-boost vaccinations ChAd3-hliNSmut and MVA-hliNSmut, administered intramuscularly in healthy volunteers and DAA treated patients. To read the entire study, click here Share This PageFollow Us … Continue reading → The post The study is aimed at assessing the safety and immunogenicity of HCV […]

The purpose of this study is to evaluate the efficacy and tolerability of DAA-based regimens in the clinical practice in HIV/HCV-coinfected patients. Hypothesis: The efficacy and tolerability of all DAA-based regimens in the clinical practice is different to what is … Continue reading → The post Real-life Security and Efficacy of DAA-based Therapy in 1,000 […]